SOLJULI
Live / Applied — Fourth extension granted (statement of use) (as of 17 Mar 2026)
What this means for you
Not registered yet, but its 22 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98007303
- Mark type
- Stylized text
- Filed
- 22 May 2023
- Published for opposition
- 19 Mar 2024
- Attorney of record
- Robert L. Powley
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation
Owner
- Lupin Limited, Mumbai, IN
- Lupin Limited, Mumbai, IN
Prosecution history
- 18 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2026 — SOU EXTENSION 4 GRANTED
- 17 Mar 2026 — SOU EXTENSION 4 FILED
- 17 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Oct 2025 — SOU EXTENSION 3 GRANTED
- 15 Oct 2025 — SOU EXTENSION 3 FILED
- 15 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2025 — SOU EXTENSION 2 GRANTED
- 27 Mar 2025 — SOU EXTENSION 2 FILED
- 27 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jun 2024 — SOU EXTENSION 1 GRANTED
- 21 Jun 2024 — SOU EXTENSION 1 FILED